Carisma Therapeutics Shares Outstanding 2012-2024 | CARM

Carisma Therapeutics shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Carisma Therapeutics Shares Outstanding 2012-2024 | CARM

Carisma Therapeutics shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$89B
Takeda Pharmaceutical (TAK)$47.2B
Merck (MKGAF)$23.7B
Astellas Pharma (ALPMY)$22.1B
Summit Therapeutics (SMMT)$17.8B
Sandoz Group AG (SDZNY)$17.6B
United Therapeutics (UTHR)$15.2B
Shionogi (SGIOY)$13.1B
Neurocrine Biosciences (NBIX)$12.1B
Catalent (CTLT)$10.9B
Orion OYJ (ORINY)$7.4B
Revolution Medicines (RVMD)$7.4B
Jazz Pharmaceuticals (JAZZ)$6.8B
Ionis Pharmaceuticals (IONS)$6.2B
Hikma Pharmaceuticals Plc (HKMPF)$5.7B
Madrigal Pharmaceuticals (MDGL)$5.1B
Corcept Therapeutics (CORT)$4.4B
Crinetics Pharmaceuticals (CRNX)$4.2B
Dyne Therapeutics (DYN)$3.4B
PTC Therapeutics (PTCT)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.7B
Arrowhead Pharmaceuticals (ARWR)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.4B
Soleno Therapeutics (SLNO)$2.1B
Recursion Pharmaceuticals (RXRX)$1.9B
Centessa Pharmaceuticals (CNTA)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.6B
Xencor (XNCR)$1.6B
Harrow (HROW)$1.6B
Cassava Sciences (SAVA)$1.5B